ATC Group: N05BX03 Etifoxine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N05BX03 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N05 Psycholeptics
3 N05B Anxiolytics
4 N05BX Other anxiolytics
5 N05BX03 Etifoxine

Active ingredients in N05BX03

Active Ingredient Description
Etifoxine

Etifoxine is a nonbenzodiazepine anxiolytic agent and acts as a GABAA receptor positive allosteric modulator and as a ligand for translocator proteins. Both mechanisms are conjectured to contribute to its anxiolytic properties. Etifoxine primarily indicated for short-term management of adjustment disorder, specifically instances of situational depression accompanied by anxiety, such as stress-induced anxiety.

Related product monographs

Title Information Source Document Type  
STRESAM Capsule MPI, EU: SmPC

Medicines in this ATC group

France (FR)

Malta (MT)

South Africa (ZA)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.